Blog
Elotuzumab Biosimilar: A New Frontier in Multiple Myeloma Treatment
Elotuzumab is a monoclonal antibody that targets SLAMF7 (signaling lymphocytic activation molecule F7), a protein highly expressed on multiple myeloma (MM) cells and natural killer (NK)
…
26th Nov 2024